ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 161 filers reported holding ARCUS BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $85,801,933 | -7.3% | 4,780,052 | +4.9% | 0.01% | -12.5% |
| Q2 2023 | $92,568,349 | -23.3% | 4,557,772 | -31.1% | 0.01% | +33.3% |
| Q1 2023 | $120,742,818 | +76.1% | 6,619,672 | +99.6% | 0.01% | -14.3% |
| Q4 2022 | $68,570,992 | -21.9% | 3,315,812 | -1.2% | 0.01% | -22.2% |
| Q3 2022 | $87,773,000 | +4.3% | 3,355,248 | +1.0% | 0.01% | +12.5% |
| Q2 2022 | $84,158,000 | -19.7% | 3,321,156 | +0.0% | 0.01% | 0.0% |
| Q1 2022 | $104,795,000 | -18.9% | 3,320,514 | +4.0% | 0.01% | -20.0% |
| Q4 2021 | $129,237,000 | +19.9% | 3,193,396 | +3.3% | 0.01% | +11.1% |
| Q3 2021 | $107,789,000 | +27.0% | 3,091,165 | 0.0% | 0.01% | +28.6% |
| Q2 2021 | $84,883,000 | +35.3% | 3,091,165 | +38.4% | 0.01% | +40.0% |
| Q1 2021 | $62,721,000 | +8.2% | 2,233,660 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $57,986,000 | +43.9% | 2,233,660 | -5.0% | 0.01% | +25.0% |
| Q3 2020 | $40,295,000 | -39.8% | 2,350,942 | -13.1% | 0.00% | -42.9% |
| Q2 2020 | $66,936,000 | +5957.6% | 2,705,575 | +3297.7% | 0.01% | – |
| Q1 2020 | $1,105,000 | – | 79,630 | +132616.7% | 0.00% | – |
| Q2 2019 | $0 | – | 60 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |